|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 18829742.8 (espacenet) (Federated) (European Patent Register), 20181205 | | Patent/reg. no. and date | DK/EP 3720879, 20220511 | | Publication date | 20201014 | | Priority no. and date | US 201762594755 P, 20171205 | | EP pub. no. and date |
EP 3720879 20201014 | | Effective date | | | Applicant/owner | Progastrine et Cancers S.à r.l., 11, Côte d'Eich
1450 Luxembourg, LU | | Applicant ref. no. | V443374DK00 | | Inventor | PRIEUR, Alexandre, 24 rue de la Cavalerie
34000 Montpellier, FR | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/26 (2006.01) , C07K 16/28 (2006.01) | | Title | Kombinationsterapi mellem anti-progastrin-antistof og immunterapi til behandling af cancer | | Int. application no. | EP2018083651 | | Int. publication no. | WO2019110662 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
